RDY FY 2017 Earnings Report — Dr. Reddy's Laboratories Limited Revenue & Financial Results | Market Cap Arena

Dr. Reddy's Laboratories LimitedRDY

FY 2017 Earnings

Reported June 19, 2017

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2017	Prior Q	FY 2016	QoQ Change	YoY Change
Revenue	$1.5B	—	$1.6B	—	-9.0%
Op. Income	$143M	—	$315M	—	-54.4%
Gross Margin	55.6%	—	59.6%	—	-4.0pp
Net Margin	8.5%	—	12.9%	—	-4.4pp
EPS (Diluted)	$0.77	—	$1.24	—	-38.4%
Free Cash Flow	-$207M	—	$280M	—	-173.8%

Revenue Flow

Item	Amount
REVENUE	$1.5B
Cost of Revenue	$663M
GROSS PROFIT	$832M
R&D Expenses	$208M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$492M
Other Expenses	-$12M
Operating Expenses	$689M
Cost & Expenses	$1.4B
OPERATING INCOME	$143M
Interest Income	$6M
Interest Expense	$7M
Other Income/Expenses	$12M
INCOME BEFORE TAX	$156M
Income Tax Expense	$28M
Net Income from Continuing Ops	$128M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$128M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$128M
D&A	$120M
EBIT	$162M
EBITDA	$261M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$1.5B
Cost of Revenue	$663M
GROSS PROFIT	$832M
R&D Expenses	$208M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$492M
Other Expenses	-$12M
Operating Expenses	$689M
Cost & Expenses	$1.4B
OPERATING INCOME	$143M
Interest Income	$6M
Interest Expense	$7M
Other Income/Expenses	$12M
INCOME BEFORE TAX	$156M
Income Tax Expense	$28M
Net Income from Continuing Ops	$128M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$128M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$128M
D&A	$120M
EBIT	$162M
EBITDA	$261M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$128M
Depreciation & Amortization	$120M
Stock-Based Compensation	$4M
Deferred Income Tax	$28M
Other Non-Cash Items	$6M
Change in Working Capital	-$57M
OPERATING CASH FLOW	$228M
Capital Expenditure	-$435M
Acquisitions (Net)	-$1M
Purchases of Investments	-$527M
Sales/Maturities of Investments	$760M
Other Investing Activities	$7M
NET CASH FROM INVESTING	-$196M
Net Debt Issuance	-$55M
Common Stock Repurchased	-$167M
Common Dividends Paid	-$36M
Other Financing Activities	$219M
NET CASH FROM FINANCING	-$39M
FREE CASH FLOW	-$207M
Net Change in Cash	-$12M

Balance Sheet

Item	Amount
Cash & Equivalents	$193M
Short-Term Investments	$0
Net Receivables	$486M
Inventory	$303M
Other Current Assets	$159M
TOTAL CURRENT ASSETS	$1.1B
PP&E (Net)	$607M
Goodwill	$40M
Intangible Assets	$477M
Long-Term Investments	$73M
Tax Assets	$59M
Other Non-Current Assets	$13M
TOTAL NON-CURRENT ASSETS	$1.3B
TOTAL ASSETS	$2.3B
Account Payables	$0
Short-Term Debt	$464M
Deferred Revenue	$9M
Other Current Liabilities	$95M
TOTAL CURRENT LIABILITIES	$903M
Long-Term Debt	$52M
Deferred Revenue NC	$34M
Deferred Tax Liabilities	$13M
Other Non-Current Liabilities	$57M
TOTAL NON-CURRENT LIABILITIES	$114M
TOTAL LIABILITIES	$1.0B
Common Stock	$9M
Additional Paid-In Capital	$78M
Retained Earnings	$1.1B
Treasury Stock	$0
Accum. Other Comp. Income	$83M
Other Equity	-$2M
TOTAL STOCKHOLDERS' EQUITY	$1.3B
Minority Interest	$0
TOTAL EQUITY	$1.3B
TOTAL LIABILITIES & EQUITY	$2.3B
Total Debt	$522M
Net Debt	$330M